Dexcom Inc’s recently made public that its Director Heller Bridgette P unloaded Company’s shares for reported $24756.0 on Mar 17 ’25. In the deal valued at $70.33 per share,352 shares were sold. As a result of this transaction, Heller Bridgette P now holds 22,997 shares worth roughly $1.42 million.
Then, Heller Bridgette P bought 352 shares, generating $24,756 in total proceeds.
Before that, Leach Jacob Steven sold 14,076 shares. Dexcom Inc shares valued at $990,670 were divested by the EVP, Chief Operating Officer at a price of $70.38 per share. As a result of the transaction, Leach Jacob Steven now holds 313,497 shares, worth roughly $19.32 million.
Redburn Atlantic upgraded its Dexcom Inc [DXCM] rating to a Buy from a a Neutral in a research note published on February 03, 2025; the price target was increased to $115 from $85. A number of analysts have revised their coverage, including Robert W. Baird’s analysts, who increased its forecast for the stock in mid January from “a Neutral” to “an Outperform”. Robert W. Baird also remained covering DXCM and has decreased its forecast on July 26, 2024 with a “Neutral” recommendation from previously “an Outperform” rating. JP Morgan revised its rating on July 26, 2024. It rated DXCM as “a Neutral” which previously was an “an Overweight”.
Price Performance Review of DXCM
On Monday, Dexcom Inc [NASDAQ:DXCM] saw its stock jump 3.01% to $61.63. Over the last five days, the stock has lost -9.75%. Dexcom Inc shares have fallen nearly -20.75% since the year began. Nevertheless, the stocks have fallen -53.78% over the past one year. While a 52-week high of $141.99 was reached on 02/18/25, a 52-week low of $57.52 was recorded on 04/04/25. SMA at 50 days reached $79.60, while 200 days put it at $80.02.
Levels Of Support And Resistance For DXCM Stock
The 24-hour chart illustrates a support level at 58.79, which if violated will result in even more drops to 55.94. On the upside, there is a resistance level at 63.69. A further resistance level may holdings at 65.74. The Relative Strength Index (RSI) on the 14-day chart is 29.35, which indicates oversold technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at -8.02, which suggests price will go down in the next trading period. Percent R suggests that price movement has been bearish at 78.08%. Stochastics %K at 12.13% indicates the stock is a buying.
How much short interest is there in Dexcom Inc?
A steep rise in short interest was recorded in Dexcom Inc stocks on 2025-03-14, growing by 1.99 million shares to a total of 11.47 million shares. Yahoo Finance data shows the prior-month short interest on 2025-02-14 was 9.48 million shares. There was a rise of 17.37%, which implies that there is a positive sentiment for the stock.
The most recent change occurred on May 30, 2024 when Redburn Atlantic began covering the stock and recommended ‘”a Neutral”‘ rating along with a $130 price target.
